TrianglePUBLICATIONS · 34343033
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Oct 1
- First author
- Kang YK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kang YK
- type
- Author
- name
- George S
- type
- Author
- name
- Jones RL
- type
- Author
- name
- Rutkowski P
- type
- Author
- name
- Shen L
- type
- Author
- name
- Mir O
- type
- Author
- name
- Patel S
- type
- Author
- name
- Zhou Y
- type
- Author
- name
- von Mehren M
- type
- Author
- name
- Hohenberger P
- type
- Author
- name
- Villalobos V
- type
- Author
- name
- Brahmi M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kang YK
- type
- Author
- name
- George S
- type
- Author
- name
- Jones RL
- type
- Author
- name
- Rutkowski P
- type
- Author
- name
- Shen L
- type
- Author
- name
- Mir O
- type
- Author
- name
- Patel S
- type
- Author
- name
- Zhou Y
- type
- Author
- name
- von Mehren M
- type
- Author
- name
- Hohenberger P
- type
- Author
- name
- Villalobos V
- type
- Author
- name
- Brahmi M
- type
- Author
- bibliography ids
- nci-bib-a4dd35c83e72a856cee6707c
- book metadata
- content sha256
- 4c08daecf270d08f85a32987b111a3c405aaa49379f03cf8c08853506dd7432b
- document type
- citation
- dois
- 10.1200/JCO.21.00217
- electronic publication date
- display
- 2021 Aug 3
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34343033
- immutable id
- pubmed:34343033@4c08daecf270d08f85a32987b111a3c405aaa49379f03cf8c08853506dd7432b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3128-3139
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34343033
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- e09a9230c783ff3cc2eb0da5dcc96dd09b39d4e6bef2ae398750b139502967aa
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Oct 1
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.
Preserved source evidence · Not medical advice